tiprankstipranks
Advertisement
Advertisement

RADX Stock Latest News

Radiopharm initiated with a Buy at H.C. Wainwright
The FlyRadiopharm initiated with a Buy at H.C. Wainwright
30m ago
RADX
Radiopharm announces new data from Phase 0/1 HEAT trial
PremiumThe Fly
Radiopharm announces new data from Phase 0/1 HEAT trial
1M ago
RADX
Radiopharm Theranostics Moves HER2 Radiotherapy Candidate RAD202 to Higher Dose in Phase 1 Trial
PremiumCompany Announcements
Radiopharm Theranostics Moves HER2 Radiotherapy Candidate RAD202 to Higher Dose in Phase 1 Trial
2M ago
6K
RADX
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
PremiumThe Fly
Radiopharm gets DSMC recommendation to advance 177Lu-RAD202 to next dose
2M ago
RADX
Radiopharm Theranostics Taps Siemens for U.S. Supply of Fast-Tracked Brain Metastases Imaging Agent RAD101
PremiumCompany Announcements
Radiopharm Theranostics Taps Siemens for U.S. Supply of Fast-Tracked Brain Metastases Imaging Agent RAD101
2M ago
6K
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
RADX
SMMT
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial
Premium
Company Announcements
Radiopharm Theranostics Doses First Patient in Phase 1 RAD 402 Prostate Cancer Trial
2M ago
6K
RADX
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
Premium
Ratings
Buy Rating on RADX Driven by Promising RAD 101 Phase 2b Imaging Data and Clear 2026 Clinical Milestones
2M ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
RADX
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart
PremiumCompany Announcements
Radiopharm Theranostics Doses First Patient in Phase 1/2a Trial of 177Lu-BetaBart
3M ago
6K
RADX
Radiopharm doses first patient in Phase 1/2a study of BetaBart
PremiumThe Fly
Radiopharm doses first patient in Phase 1/2a study of BetaBart
3M ago
RADX
Radiopharm reports cash balance of $34.52M as of December 31
PremiumThe Fly
Radiopharm reports cash balance of $34.52M as of December 31
4M ago
RADX
Radiopharm Theranostics Lifts Stake in MD Anderson Joint Venture to 87.5% as Lead B7H3 Drug Enters Clinic
PremiumCompany AnnouncementsRadiopharm Theranostics Lifts Stake in MD Anderson Joint Venture to 87.5% as Lead B7H3 Drug Enters Clinic
5M ago
6K
RADX
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
Premium
The Fly
Radiopharm increases ownership in Radiopharm Ventures to 87.5%
5M ago
RADX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
AIM
RADX
Radiopharm price target raised to $15 from $12 at Maxim
PremiumThe Fly
Radiopharm price target raised to $15 from $12 at Maxim
6M ago
RADX
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
PremiumRatings
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
6M ago
RADX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
RADX
Radiopharm price target raised to $16 from $13 at B. Riley
PremiumThe Fly
Radiopharm price target raised to $16 from $13 at B. Riley
6M ago
RADX
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Monday’s Biggest Stock Market Stories!
6M ago
AMD
GOOG
Why Is Radiopharm Theranostics Stock (RADX) Up Today?
Premium
Market News
Why Is Radiopharm Theranostics Stock (RADX) Up Today?
6M ago
RADX
Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial
Premium
The Fly
Radiopharm achieves primary endpoint in 92% of patients in RAD 101 trial
6M ago
RADX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >